Zhe Zhang

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Xu-Hua Guan, Yu-Hua Li et al. · The Lancet · 2020 · 1.3K citations · Full text

HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry

Congwen Wei, Luming Wan, Qiulin Yan et al. · Nature Metabolism · 2020 · 296 citations · Full text

Immunology, Receptor (Biochemistry), Sars-cov-2 Entry +2

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial

Shipo Wu, Jianying Huang, Zhe Zhang et al. · The Lancet Infectious Diseases · 2021 · 291 citations · Full text

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Shipo Wu, Gongxun Zhong, Jun Zhang et al. · Nature Communications · 2020 · 284 citations · Full text

Polyvinyl chloride degradation by a bacterium isolated from the gut of insect larvae

Zhe Zhang, Haoran Peng, Dongchen Yang et al. · Nature Communications · 2022 · 229 citations · Full text